Neisseria meningitidis (the meningococcus) causes significant morbidity and mortality in children and young adults worldwide through epidemic or sporadic meningitis and/or …
The epidemiology of invasive meningococcal disease continues to change rapidly, even in the three years since the first Meningococcal Exchange Meeting in 2008. Control of disease …
England and Wales are experiencing a year-on-year increase in meningococcal group W (MenW) disease since 2009–2010, following rapid expansion of a single endemic …
R Booy, A Gentile, M Nissen, J Whelan… - Human vaccines & …, 2019 - Taylor & Francis
Invasive meningococcal disease (IMD) is a serious disease that is fatal in 5–15% and disabling in 12–20% of cases. The dynamic and unpredictable epidemiology is a particular …
Following an outbreak in Mecca Saudi Arabia in 2000, meningococcal strains expressing capsular group W (W) emerged as a major cause of invasive meningococcal disease (IMD) …
Neisseria meningitidis causes endemic meningococcal disease worldwide. Serogroups B and C are responsible for the majority of cases of meningococcal disease in Europe …
R Abad, EL López, R Debbag… - Epidemiology & Infection, 2014 - cambridge.org
Meningococcal serogroup W strains have been emerging throughout the current century with most of the isolates belonging to the sequence type (ST11)/electrophoretic type (ET37) …
Neisseria meningitidis is a leading bacterial cause of sepsis and meningitis globally with dynamic strain distribution over time. Beginning with an epidemic among Hajj pilgrims in …
A Arguedas, C Soley, C Loaiza, G Rincon, S Guevara… - Vaccine, 2010 - Elsevier
This Phase III study evaluates an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM (Novartis Vaccines), when administered concomitantly …